Back to User profile » Prof. Dr. Ming Zhao
Papers published by Prof. Dr. Ming Zhao:
BCESA: a nano-scaled intercalator capable of targeting tumor tissue and releasing anti-tumoral β-carboline-3-carboxylic acid
Wu J, Cui Y, Zhang X, Gui L, Wang Y, Peng S, Zhao M
International Journal of Nanomedicine 2019, 14:3027-3041
Published Date: 30 April 2019
Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
Chen H, Lu A, Zhang X, Gui L, Wang YN, Wu J, Feng H, Peng S, Zhao M
Drug Design, Development and Therapy 2018, 12:2097-2110
Published Date: 9 July 2018
Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
Wu J, Zhu H, Yang G, He J, Wang Y, Zhao S, Zhang X, Gui L, Zhao M, Peng S
International Journal of Nanomedicine 2018, 13:1139-1158
Published Date: 26 February 2018
ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo
Xu X, Wang Y, Wu J, Hu X, Zhu H, Zhang X, Wang YN, Gui L, Zhao M, Peng S
International Journal of Nanomedicine 2017, 12:4415-4431
Published Date: 13 June 2017
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation
Wu JH, Zhao M, Wang YJ, Wang YN, Zhu HM, Zhao SR, Gui L, Zhang XY, Peng SQ
Drug Design, Development and Therapy 2017, 11:225-239
Published Date: 17 January 2017
Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: a nanomedicine strategy to improve the outcome of cisplatin therapy
Lv X, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S
Drug Design, Development and Therapy 2016, 10:3933-3946
Published Date: 1 December 2016
Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT
Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X, Li S, Cui C, Peng S
Drug Design, Development and Therapy 2016, 10:2701-2711
Published Date: 30 August 2016
RGD(F/S/V)-Dex: towards the development of novel, effective, and safe glucocorticoids
Jiang X, Zhao M, Wang Y, Zhu H, Zhao S, Wu J, Song Y, Peng S
Drug Design, Development and Therapy 2016, 10:1059-1076
Published Date: 8 March 2016
5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors
Gan T, Wang Y, Zhao M, Wu J, Yang J, Peng S
Drug Design, Development and Therapy 2016, 10:711-721
Published Date: 16 February 2016
Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis
Wang Y, Tang J, Zhu H, Jiang X, Liu J, Xu W, Ma H, Feng Q, Wu J, Zhao M, Peng S
International Journal of Nanomedicine 2015, 10:6905-6918
Published Date: 4 November 2015
Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis
Li S, Wang Y, Wang F, Wang Y, Zhang X, Zhao M, Feng Q, Wu J, Zhao S, Wu W, Peng S
International Journal of Nanomedicine 2015, 10:5273-5292
Published Date: 24 August 2015
Modifying tetramethyl–nitrophenyl–imidazoline with amino acids: design, synthesis, and 3D-QSAR for improving inflammatory pain therapy
Jiang X, Wang Y, Zhu H, Wang Y, Zhao M, Zhao S, Wu J, Li S, Peng S
Drug Design, Development and Therapy 2015, 9:2329-2342
Published Date: 22 April 2015
Cu2+-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy
Wu J, Wang Y, Wang Y, Zhao M, Zhang X, Gui L, Zhao S, Zhu H, Zhao J, Peng S
International Journal of Nanomedicine 2015, 10:2925-2938
Published Date: 15 April 2015